Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910973 · ClinicalTrials.gov registry record · NA
Using a Transcutaneous Electrical Auricular Stimulator to Harness the Cholinergic Anti-Inflammatory Pathway
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02910973 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 16 participants.
The verdict
NCT02910973, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Persistent chronic inflammation is an important underlying event in multiple diseases including rheumatoid arthritis, inflammatory bowel diseases and type 2 diabetes. These disorders are characterized as inflammatory in part because of the important mediating role of pro-inflammatory cytokines in their pathogenesis. This study will investigate whether transcutaneous auricular electrical stimulation of the vagus nerve will affect and decrease the inflammatory cytokine response in healthy individuals.
Interventions
- DEVICE Vagus Nerve Stimulation
- DEVICE Sham Vagus Nerve Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-09 |
| Est. Completion | 2023-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02910973
The ClinicalTrials.gov registry entry for NCT02910973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vagus Nerve Stimulation is the first listed.
NCT02910973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02910973 about?
NCT02910973 is a clinical study titled "Using a Transcutaneous Electrical Auricular Stimulator to Harness the Cholinergic Anti-Inflammatory Pathway". Persistent chronic inflammation is an important underlying event in multiple diseases including rheumatoid arthritis, inflammatory bowel diseases and type 2 diabetes. These disorders are characterized as inflammatory in part because of the important mediating role of pro-inflammatory cytokines in th...
What is the current status of trial NCT02910973?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-09. Estimated completion is 2023-12-13.
What interventions are being tested in trial NCT02910973?
The interventions under investigation include: Vagus Nerve Stimulation (DEVICE), Sham Vagus Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02910973?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.